These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| New York | 13-1432060 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
| Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o |
| ITEM 1. |
FINANCIAL STATEMENTS
|
| March 31, | December 31, | |||||||
| 2011 | 2010 | |||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 111,970 | $ | 131,332 | ||||
|
Trade receivables
|
526,395 | 458,128 | ||||||
|
Allowance for doubtful accounts
|
(6,317 | ) | (6,324 | ) | ||||
|
Inventories: Raw materials
|
286,744 | 270,191 | ||||||
|
Work in process
|
9,455 | 6,211 | ||||||
|
Finished goods
|
263,351 | 255,273 | ||||||
|
|
||||||||
|
Total Inventories
|
559,550 | 531,675 | ||||||
|
Deferred income taxes
|
58,573 | 74,160 | ||||||
|
Prepaid expenses and other current assets
|
137,448 | 136,224 | ||||||
|
|
||||||||
|
Total Current Assets
|
1,387,619 | 1,325,195 | ||||||
|
|
||||||||
|
|
||||||||
|
Property, plant and equipment, at cost
|
1,372,848 | 1,344,883 | ||||||
|
Accumulated depreciation
|
(821,766 | ) | (806,765 | ) | ||||
|
|
||||||||
|
|
551,082 | 538,118 | ||||||
|
|
||||||||
|
|
||||||||
|
Goodwill
|
665,582 | 665,582 | ||||||
|
Other intangible assets, net
|
47,317 | 48,834 | ||||||
|
Deferred income taxes
|
120,793 | 122,800 | ||||||
|
Other assets
|
174,153 | 171,926 | ||||||
|
|
||||||||
|
Total Assets
|
$ | 2,946,546 | $ | 2,872,455 | ||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Bank borrowings and overdrafts and current portion of long-term debt
|
$ | 185,108 | $ | 133,899 | ||||
|
Accounts payable
|
185,205 | 200,153 | ||||||
|
Accrued payroll and bonus
|
40,514 | 95,135 | ||||||
|
Dividends payable
|
21,733 | 21,657 | ||||||
|
Restructuring and other charges
|
2,781 | 3,977 | ||||||
|
Other current liabilities
|
198,631 | 206,130 | ||||||
|
|
||||||||
|
Total Current Liabilities
|
633,972 | 660,951 | ||||||
|
|
||||||||
|
|
||||||||
|
Long-term debt
|
786,980 | 787,668 | ||||||
|
Deferred gains
|
50,160 | 50,917 | ||||||
|
Retirement liabilities
|
222,905 | 221,985 | ||||||
|
Other liabilities
|
149,683 | 147,779 | ||||||
|
|
||||||||
|
Total Other Liabilities
|
1,209,728 | 1,208,349 | ||||||
|
|
||||||||
|
|
||||||||
|
Commitments and Contingencies (Note 12)
|
||||||||
|
|
||||||||
|
Shareholders Equity:
|
||||||||
|
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,761,840
shares as of March 31, 2011 and December 31, 2010; and outstanding
80,357,478 and 80,210,365 shares as of March 31, 2011 and December 31, 2010
|
14,470 | 14,470 | ||||||
|
Capital in excess of par value
|
125,448 | 123,809 | ||||||
|
Retained earnings
|
2,582,057 | 2,519,706 | ||||||
|
Accumulated other comprehensive loss
|
(245,914 | ) | (275,351 | ) | ||||
|
Treasury stock, at cost 35,404,362 shares as of March 31, 2011 and 35,551,475
shares as of December 31, 2010
|
(1,377,499 | ) | (1,383,212 | ) | ||||
|
|
||||||||
|
Total Shareholders Equity
|
1,098,562 | 999,422 | ||||||
|
|
||||||||
|
Noncontrolling interest
|
4,284 | 3,733 | ||||||
|
|
||||||||
|
Total Shareholders Equity including noncontrolling interest
|
1,102,846 | 1,003,155 | ||||||
|
|
||||||||
|
Total Liabilities and Shareholders Equity
|
$ | 2,946,546 | $ | 2,872,455 | ||||
|
|
||||||||
2
| Three Months Ended March 31, | ||||||||
| 2011 | 2010 | |||||||
|
Net sales
|
$ | 714,271 | $ | 653,909 | ||||
|
|
||||||||
|
|
||||||||
|
Cost of goods sold
|
416,811 | 383,702 | ||||||
|
Research and development expenses
|
57,456 | 52,631 | ||||||
|
Selling and administrative expenses
|
106,619 | 108,009 | ||||||
|
Restructuring and other charges, net
|
28 | 4,988 | ||||||
|
Interest expense
|
11,680 | 12,736 | ||||||
|
Other expense, net
|
6,056 | 2,762 | ||||||
|
|
||||||||
|
|
598,650 | 564,828 | ||||||
|
|
||||||||
|
Income before taxes on income
|
115,621 | 89,081 | ||||||
|
Taxes on income
|
31,578 | 25,292 | ||||||
|
|
||||||||
|
Net income
|
84,043 | 63,789 | ||||||
|
|
||||||||
|
Other comprehensive income:
|
||||||||
|
Foreign currency translation adjustments
|
28,808 | (11,076 | ) | |||||
|
(Losses) gains on derivatives
qualifying as hedges
|
(2,048 | ) | 286 | |||||
|
Pension and postretirement net liability
adjustment
|
2,677 | 1,792 | ||||||
|
|
||||||||
|
Comprehensive income
|
$ | 113,480 | $ | 54,791 | ||||
|
|
||||||||
|
|
||||||||
|
Net income per share basic
|
$ | 1.04 | $ | 0.80 | ||||
|
|
||||||||
|
Net income per share diluted
|
$ | 1.03 | $ | 0.80 | ||||
|
|
||||||||
|
Average number of shares outstanding basic
|
80,049 | 78,767 | ||||||
|
|
||||||||
|
Average number of shares outstanding diluted
|
81,150 | 79,692 | ||||||
|
|
||||||||
|
Dividends declared per share
|
$ | 0.27 | $ | 0.25 | ||||
3
| Three Months Ended March 31, | ||||||||
| 2011 | 2010 | |||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 84,043 | $ | 63,789 | ||||
|
Adjustments to reconcile to net cash provided by operations:
|
||||||||
|
Depreciation and amortization
|
17,962 | 20,032 | ||||||
|
Deferred income taxes
|
17,915 | (5,169 | ) | |||||
|
Gain on disposal of assets
|
(807 | ) | (623 | ) | ||||
|
Equity based compensation
|
6,329 | 5,461 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Current receivables
|
(55,564 | ) | (29,292 | ) | ||||
|
Inventories
|
(11,933 | ) | (6,056 | ) | ||||
|
Current payables
|
(93,103 | ) | (13,707 | ) | ||||
|
Other assets
|
9,122 | (4,261 | ) | |||||
|
Other liabilities
|
(8,908 | ) | 2,218 | |||||
|
|
||||||||
|
Net cash (used in) provided by operations
|
(34,944 | ) | 32,392 | |||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property, plant and equipment
|
(19,375 | ) | (12,950 | ) | ||||
|
Purchase of investments
|
(217 | ) | (1,856 | ) | ||||
|
Proceeds from disposal of assets
|
144 | 64 | ||||||
|
|
||||||||
|
Net cash used in investing activities
|
(19,448 | ) | (14,742 | ) | ||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Cash dividends paid to shareholders
|
(21,657 | ) | (19,786 | ) | ||||
|
Net change in bank borrowings and overdrafts
|
51,572 | 5,351 | ||||||
|
Proceeds from issuance of stock under stock-based
compensation plans
|
3,479 | 7,372 | ||||||
|
Excess tax benefits on share-based payments
|
816 | | ||||||
|
|
||||||||
|
Net cash provided by (used in) financing activities
|
34,210 | (7,063 | ) | |||||
|
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
820 | (904 | ) | |||||
|
|
||||||||
|
Net change in cash and cash equivalents
|
(19,362 | ) | 9,683 | |||||
|
Cash and cash equivalents at beginning of year
|
131,332 | 80,135 | ||||||
|
|
||||||||
|
Cash and cash equivalents at end of period
|
$ | 111,970 | $ | 89,818 | ||||
|
|
||||||||
|
|
||||||||
|
Interest paid
|
$ | 26,344 | $ | 26,442 | ||||
|
|
||||||||
|
Income taxes paid
|
$ | 20,337 | $ | 12,164 | ||||
4
| Three Months Ended March 31, | ||||||||
| (Shares in thousands) | 2011 | 2010 | ||||||
|
Basic
|
80,049 | 78,767 | ||||||
|
Assumed dilution under stock plans
|
1,101 | 925 | ||||||
|
|
||||||||
|
Diluted
|
81,150 | 79,692 | ||||||
|
|
||||||||
5
| Asset- | ||||||||||||
| Employee- | Related | |||||||||||
| (DOLLARS IN THOUSANDS) | Related | and Other | Total | |||||||||
|
Balance December 31, 2010
|
$ | 3,977 | $ | | $ | 3,977 | ||||||
|
Additional charges (reversals), net
|
(516 | ) | 544 | 28 | ||||||||
|
Payments and other costs
|
(680 | ) | (544 | ) | (1,224 | ) | ||||||
|
|
||||||||||||
|
Balance March 31, 2011
|
$ | 2,781 | $ | | $ | 2,781 | ||||||
|
|
||||||||||||
| (DOLLARS IN THOUSANDS) | Amount | |||
|
Flavors
|
$ | 319,479 | ||
|
Fragrances
|
346,103 | |||
|
|
||||
|
Total
|
$ | 665,582 | ||
|
|
||||
| March 31, | December 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Gross carrying value
(1)
|
$ | 165,406 | $ | 165,406 | ||||
|
Accumulated amortization
|
(118,089 | ) | (116,572 | ) | ||||
|
|
||||||||
|
Total
|
$ | 47,317 | $ | 48,834 | ||||
|
|
||||||||
| (1) |
Includes patents, trademarks and other intellectual property, valued at acquisition,
primarily through independent appraisals.
|
6
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2010
|
$ | (74,826 | ) | $ | (4,183 | ) | $ | (196,342 | ) | $ | (275,351 | ) | ||||
|
Change
|
28,808 | (2,048 | ) | 2,677 | 29,437 | |||||||||||
|
|
||||||||||||||||
|
Balance March 31, 2011
|
$ | (46,018 | ) | $ | (6,231 | ) | $ | (193,665 | ) | $ | (245,914 | ) | ||||
|
|
||||||||||||||||
| Accumulated (losses) | Pension and | |||||||||||||||
| gains on derivatives | postretirement net | |||||||||||||||
| Translation | qualifying as hedges, | liability adjustment, | ||||||||||||||
| (DOLLARS IN THOUSANDS) | adjustments | net of tax | net of tax | Total | ||||||||||||
|
Balance December 31, 2009
|
$ | (68,606 | ) | $ | (2,741 | ) | $ | (199,627 | ) | $ | (270,974 | ) | ||||
|
Change
|
(11,076 | ) | 286 | 1,792 | (8,998 | ) | ||||||||||
|
|
||||||||||||||||
|
Balance March 31, 2010
|
$ | (79,682 | ) | $ | (2,455 | ) | $ | (197,835 | ) | $ | (279,972 | ) | ||||
|
|
||||||||||||||||
| (DOLLARS IN THOUSANDS) | Rate | Maturities | March 31, 2011 | December 31, 2010 | ||||||||||||
|
Bank borrowings and overdrafts
|
0.45 | % | $ | 63,139 | $ | 11,625 | ||||||||||
|
Current portion of long-term debt
|
5.39 | % | 121,969 | 122,274 | ||||||||||||
|
|
||||||||||||||||
|
Total current debt
|
185,108 | 133,899 | ||||||||||||||
|
|
||||||||||||||||
|
Senior notes 2007
|
6.40 | % | 2017-27 | 500,000 | 500,000 | |||||||||||
|
Senior notes 2006
|
6.10 | % | 2013-16 | 225,000 | 225,000 | |||||||||||
|
Bank borrowings
|
0.45 | % | 2012 | 49,566 | 49,771 | |||||||||||
|
Deferred realized gains on interest rate swaps
|
12,414 | 12,897 | ||||||||||||||
|
|
||||||||||||||||
|
Total long-term debt
|
786,980 | 787,668 | ||||||||||||||
|
|
||||||||||||||||
|
Total debt
|
$ | 972,088 | $ | 921,567 | ||||||||||||
|
|
||||||||||||||||
7
| Weighted Average | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | Options/SSARs | Exercise Price | ||||||
|
Balance at December 31, 2010
|
1,440 | $ | 37.46 | |||||
|
Exercised
|
(131 | ) | $ | 39.69 | ||||
|
|
||||||||
|
Balance at March 31, 2011
|
1,309 | $ | 37.21 | |||||
|
|
||||||||
8
| Weighted Average | ||||||||
| Grant Date Fair | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | RSU | Value Per Share | ||||||
|
Balance at December 31, 2010
|
1,029 | $ | 40.29 | |||||
|
Granted
|
1 | $ | 54.70 | |||||
|
Vested
|
(1 | ) | $ | 27.53 | ||||
|
Cancelled
|
(17 | ) | $ | 38.99 | ||||
|
|
||||||||
|
Balance at March 31, 2011
|
1,012 | $ | 41.32 | |||||
|
|
||||||||
| Weighted Average | ||||||||
| Grant Date Fair | ||||||||
| (SHARE AMOUNTS IN THOUSANDS) | PRS | Value Per Share | ||||||
|
Balance at December 31, 2010
|
525 | $ | 19.32 | |||||
|
Vested
|
(104 | ) | $ | 20.25 | ||||
|
|
||||||||
|
Balance at March 31, 2011
|
421 | $ | 19.08 | |||||
|
|
||||||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Restricted stock and RSUs
|
$ | 5,923 | $ | 5,119 | ||||
|
Stock options and SSARs
|
406 | 342 | ||||||
|
|
||||||||
|
Total equity compensation
expense
|
$ | 6,329 | $ | 5,461 | ||||
|
|
||||||||
9
| Three Months Ended March 31, 2011 | |||||||||||||||||
| Global | |||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | |||||||||||||
|
|
|||||||||||||||||
|
Net sales
|
$ | 338,587 | $ | 375,684 | $ | | $ | 714,271 | |||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
|
Operating profit
|
$ | 78,954 | $ | 68,676 | $ | (14,273 | ) | $ | 133,357 | ||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
|
Interest expense
|
(11,680 | ) | |||||||||||||||
|
Other expense, net
|
(6,056 | ) | |||||||||||||||
|
|
|||||||||||||||||
|
Income before taxes on income
|
$ | 115,621 | |||||||||||||||
|
|
|||||||||||||||||
| Three Months Ended March 31, 2010 | ||||||||||||||||
| Global | ||||||||||||||||
| (DOLLARS IN THOUSANDS) | Flavors | Fragrances | Expenses | Consolidated | ||||||||||||
|
|
||||||||||||||||
|
Net sales
|
$ | 300,169 | $ | 353,740 | $ | | $ | 653,909 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating profit
|
$ | 61,577 | $ | 56,015 | $ | (13,013 | ) | $ | 104,579 | |||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Interest expense
|
(12,736 | ) | ||||||||||||||
|
Other expense, net
|
(2,762 | ) | ||||||||||||||
|
|
||||||||||||||||
|
Income before taxes on income
|
$ | 89,081 | ||||||||||||||
|
|
||||||||||||||||
10
| U.S. Plans | Three Months Ended March 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Service cost for benefits earned
|
$ | 864 | $ | 910 | ||||
|
Interest cost on projected benefit obligation
|
6,007 | 5,990 | ||||||
|
Expected return on plan assets
|
(6,269 | ) | (6,042 | ) | ||||
|
Net amortization and deferrals
|
2,822 | 1,812 | ||||||
|
|
||||||||
|
Defined benefit plans
|
3,424 | 2,670 | ||||||
|
Defined contribution and other retirement plans
|
1,890 | 1,912 | ||||||
|
|
||||||||
|
Total pension expense
|
$ | 5,314 | $ | 4,582 | ||||
|
|
||||||||
| Non-U.S. Plans | Three Months Ended March 31, | |||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Service cost for benefits earned
|
$ | 2,612 | $ | 2,558 | ||||
|
Interest cost on projected benefit obligation
|
8,522 | 8,411 | ||||||
|
Expected return on plan assets
|
(11,345 | ) | (10,601 | ) | ||||
|
Net amortization and deferrals
|
1,352 | 1,345 | ||||||
|
|
||||||||
|
Defined benefit plans
|
1,141 | 1,713 | ||||||
|
Defined contribution and other retirement plans
|
1,403 | 971 | ||||||
|
|
||||||||
|
Total pension expense
|
$ | 2,544 | $ | 2,684 | ||||
|
|
||||||||
| Three Months Ended March 31, | ||||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Service cost for benefits earned
|
$ | 258 | $ | 410 | ||||
|
Interest on benefit obligation
|
1,454 | 1,643 | ||||||
|
Net amortization and deferrals
|
(672 | ) | (489 | ) | ||||
|
|
||||||||
|
Total postretirement benefit expense
|
$ | 1,040 | $ | 1,564 | ||||
|
|
||||||||
11
| |
Level 1Quoted prices for
identical
instruments in active markets.
|
||
| |
Level 2Quoted prices for
similar
instruments in active markets; quoted
prices for identical or similar instruments in markets that are not active;
and model-derived valuations in which all significant inputs and significant
value drivers are observable in active markets.
|
||
| |
Level 3Valuations derived from valuation techniques in which one or more
significant inputs or significant value drivers are unobservable
.
|
12
| (DOLLARS IN THOUSANDS) | March 31, 2011 | December 31, 2010 | ||||||
|
Forward currency contracts
|
$ | 215,700 | $ | 141,050 | ||||
|
Interest rate swaps
|
$ | 116,209 | $ | 116,209 | ||||
13
| March 31, 2011 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total | ||||||||||
| (DOLLARS IN THOUSANDS) | Instruments | Instruments | Fair Value | |||||||||
|
|
||||||||||||
|
Derivative assets
(a)
|
||||||||||||
|
Foreign currency contracts
|
$ | 261 | $ | 1,792 | $ | 2,053 | ||||||
|
Interest rate swap
|
77 | | 77 | |||||||||
|
|
||||||||||||
|
|
$ | 338 | $ | 1,792 | $ | 2,130 | ||||||
|
|
||||||||||||
|
Derivative liabilities
(b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 9,745 | $ | 11,994 | $ | 21,739 | ||||||
|
Interest rate swaps
|
518 | | 518 | |||||||||
|
|
||||||||||||
|
|
$ | 10,263 | $ | 11,994 | $ | 22,257 | ||||||
| December 31, 2010 | ||||||||||||
| Fair Value of | Fair Value of | |||||||||||
| Derivatives | Derivatives Not | |||||||||||
| Designated as | Designated as | |||||||||||
| Hedging | Hedging | Total | ||||||||||
| (DOLLARS IN THOUSANDS) | Instruments | Instruments | Fair Value | |||||||||
|
|
||||||||||||
|
Derivative assets
(a)
|
||||||||||||
|
Foreign currency contracts
|
$ | 2,984 | $ | 1,491 | $ | 4,475 | ||||||
|
Interest rate swap
|
112 | | 112 | |||||||||
|
|
||||||||||||
|
|
$ | 3,096 | $ | 1,491 | $ | 4,587 | ||||||
|
|
||||||||||||
|
Derivative liabilities
(b)
|
||||||||||||
|
Foreign currency contracts
|
$ | 7,086 | $ | 9,276 | $ | 16,362 | ||||||
|
Interest rate swaps
|
348 | | 348 | |||||||||
|
|
||||||||||||
|
|
$ | 7,434 | $ | 9,276 | $ | 16,710 | ||||||
| (a) |
Derivative assets are recorded to Prepaid expenses and other current assets in the
Consolidated Balance Sheet.
|
|
| (b) |
All derivative liabilities are recorded as Other current liabilities in the Consolidated
Balance Sheet.
|
14
| Amount of Gain or (Loss) | Location of Gain | |||||||||
| Recognized in Income on | or (Loss) | |||||||||
| Derivatives Not Designated as | Derivative | Recognized in | ||||||||
| Hedging Instruments under | For the three months | Income on | ||||||||
| ASC 815 | ended March 31, | Derivative | ||||||||
| 2011 | 2010 | |||||||||
|
|
||||||||||
|
Foreign currency contracts
|
$ | (9,551 | ) | $ | (2,215 | ) | Other expense, net | |||
| Amount of Gain or | ||||||||||||||||||
| Amount of Gain or | (Loss) Reclassified | |||||||||||||||||
| (Loss) Recognized in | Location of Gain or | from Accumulated | ||||||||||||||||
| OCI on Derivative | (Loss) Reclassified | OCI into Income | ||||||||||||||||
| (Effective Portion) | from Accumulated | (Effective Portion) | ||||||||||||||||
| For the three months | OCI into Income | For the three months | ||||||||||||||||
| ended March 31, | (Effective Portion) | ended March 31, | ||||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||||
|
|
||||||||||||||||||
|
Derivatives in Cash Flow
Hedging Relationships:
|
||||||||||||||||||
|
|
||||||||||||||||||
|
Cross currency swap
(1)
|
$ | 577 | $ | 281 | Other expense, net | $ | (525 | ) | $ | (297 | ) | |||||||
|
Forward currency contracts
|
$ | (2,665 | ) | $ | | Cost of goods sold | $ | (997 | ) | $ | | |||||||
|
|
||||||||||||||||||
|
Derivatives in Net Investment
Hedging Relationships:
|
||||||||||||||||||
|
|
||||||||||||||||||
|
Forward currency contracts
|
$ | (1,451 | ) | $ | 624 | N/A | $ | | $ | | ||||||||
|
|
||||||||||||||||||
|
Total
|
$ | (3,539 | ) | $ | 905 | $ | (1,522 | ) | $ | (297 | ) | |||||||
|
|
||||||||||||||||||
| (1) |
Ten year swap executed in 2003
|
15
16
| Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of
Operations
|
17
| |
created for the exclusive use by a specific customer;
|
||
| |
sold in powder or liquid form, in amounts ranging from a few pounds to several tons
depending on the nature of the end product in which they are used;
|
||
| |
a small percentage of the volume and cost of the end product sold to the consumer;
and
|
||
| |
a major factor in consumer selection and acceptance of the product.
|
18
| % Change in Sales-First Quarter 2011 vs First Quarter 2010 | ||||||||||||||||||||||||||
| Fine & | ||||||||||||||||||||||||||
| Beauty Care | Functional | Ingredients | Total Frag. | Flavors | Total | |||||||||||||||||||||
|
North America
|
Reported | -7 | % | 1 | % | 7 | % | 1 | % | 17 | % | 9 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
EAME
|
Reported | 19 | % | -3 | % | -2 | % | 5 | % | 13 | % | 8 | % | |||||||||||||
|
|
Local Currency | 22 | % | 0 | % | 1 | % | 8 | % | 15 | % | 11 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Latin America
|
Reported | 26 | % | 0 | % | -1 | % | 9 | % | 6 | % | 8 | % | |||||||||||||
|
|
Local Currency | 23 | % | -1 | % | -1 | % | 9 | % | 4 | % | 7 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Greater Asia
|
Reported | 8 | % | 16 | % | 2 | % | 11 | % | 12 | % | 12 | % | |||||||||||||
|
|
Local Currency | 7 | % | 14 | % | 0 | % | 9 | % | 7 | % | 8 | % | |||||||||||||
|
|
||||||||||||||||||||||||||
|
Total
|
Reported | 13 | % | 3 | % | 2 | % | 6 | % | 13 | % | 9 | % | |||||||||||||
|
|
Local Currency | 14 | % | 4 | % | 3 | % | 7 | % | 12 | % | 9 | % | |||||||||||||
| |
North America Fine & Beauty Care sales declined 7% in the current quarter as a result
of very strong year-ago comparables (+24%); the elimination of stocking benefits in the
year-ago period; and lower volume by certain key customers. Functional Fragrance sales were
essentially flat versus last year as new business wins and volume gains in Home Care offset
volume erosion in Fabric and Personal Wash. The Flavors business was led by new business
performance in the Beverage and Savory categories; combined with volume gains in Savory and
Confectionery.
|
| |
EAME growth of 11% in LC terms was led by 22% growth in Fine & Beauty combined with
double-digit gains in Beverage, Dairy and Savory. New business performance in Fine Fragrance
and Hair Care was the principal driver of Fragrance growth in the region.
|
| |
Latin America sales performance was driven by high double-digit growth in Fine & Beauty
Care (reflecting both net new wins as well as growth in our customers business); whereas new
business performance and pricing in Functional Fragrance was offset by volume erosion with
our customers. Flavors growth was led by both new business and volume gains in
Confectionery.
|
19
| |
Greater Asia delivered solid 8% LC sales growth, led by double-digit gains in Fine
Fragrance, Fabric, Home Care, Beverages and Dairy. Volume gains with customers and
commercial performance of new business were essentially equal contributors to the growth.
|
| Three months ended | ||||||||
| March 31, | ||||||||
| 2011 | 2010 | |||||||
|
Cost of goods sold
|
58.4 | % | 58.7 | % | ||||
|
Research and development expenses
|
8.0 | % | 8.0 | % | ||||
|
Selling and administrative expenses
|
14.9 | % | 16.5 | % | ||||
20
21
| Restructuring Charges | ||||||||
| Three months ended March 31, | ||||||||
| (DOLLARS IN THOUSANDS) | 2011 | 2010 | ||||||
|
Fragrances
|
$ | (28 | ) | $ | (4,988 | ) | ||
|
|
||||||||
|
Total
|
$ | (28 | ) | $ | (4,988 | ) | ||
|
|
||||||||
22
| (1) |
Adjusted EBITDA and Net Debt, which are non-GAAP measures used for these covenants,
are calculated in accordance with the definition in the debt agreements. In this context, these
measures are used solely to provide information on the extent to which we are in compliance with
debt covenants and may not be comparable to adjusted
EBITDA and Net Debt used by other companies. Reconciliations of adjusted EBITDA to net income and
net debt to total debt are as follows:
|
| 12 Months Ended March 31, | ||||||||
| (DOLLARS IN MILLIONS) | 2011 | 2010 | ||||||
|
Net income
|
$ | 283.8 | $ | 212.1 | ||||
|
Interest expense
|
47.7 | 54.7 | ||||||
|
Income taxes
|
102.3 | 90.3 | ||||||
|
Depreciation
|
71.1 | 73.7 | ||||||
|
Amortization
|
6.1 | 6.2 | ||||||
|
Specified items
(1)
|
5.1 | 29.6 | ||||||
|
|
||||||||
|
Adjusted EBITDA
|
$ | 516.1 | $ | 466.6 | ||||
|
|
||||||||
| (1) |
Specified items for the 12 months ended March 31, 2011 of $5.1 million consist of
restructuring charges. Specified items for the 12 months ended March 31, 2010 of $29.6
million consist principally of restructuring charges ($23.3 million) and employee separation
costs ($6.3 million).
|
| March 31, | ||||||||
| (DOLLARS IN MILLIONS) | 2011 | 2010 | ||||||
|
Total debt
|
$ | 972.1 | $ | 1,014.9 | ||||
|
Adjustments:
|
||||||||
|
Deferred gain on interest rate swaps
|
(12.4 | ) | (14.4 | ) | ||||
|
Cash and cash equivalents
|
(112.0 | ) | (89.8 | ) | ||||
|
|
||||||||
|
Net debt
|
$ | 847.7 | $ | 910.7 | ||||
|
|
||||||||
23
| Item 3. |
Quantitative and Qualitative Disclosures about Market Risk
|
| Item 4. |
Controls and Procedures
|
24
| Item 1. |
Legal Proceedings
|
25
26
| Item 1A. |
Risk Factors
|
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
| Total Number of | ||||||||||||||||
| Total | Shares Purchased | Maximum Number | ||||||||||||||
| Number of | Average | as Part of Publicly | of Shares That May | |||||||||||||
| Shares | Price Paid | Announced | Yet Be Purchased | |||||||||||||
| Purchased | per Share | Program | Under the Program | |||||||||||||
|
January 1 31, 2011
|
| | | | ||||||||||||
|
February 1 28, 2011
|
| | | | ||||||||||||
|
March 1 31, 2011
|
| | | | ||||||||||||
|
Total shares purchased
|
| | | | ||||||||||||
27
| Item 6. |
Exhibits
|
| 3.1 |
Bylaws of International Flavors & Fragrances Inc., as amended and
restated March 8, 2011, incorporated by reference to Exhibit 3.1 to
the Companys Report on Form 8-K filed on March 11, 2011.
|
|||
|
|
||||
| 31.1 |
Certification of Douglas D. Tough pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 31.2 |
Certification of Kevin C. Berryman pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 32 |
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to
18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act
of 2002.
|
| Dated: May 10, 2011 | By: | /s/ Douglas D. Tough | ||
| Douglas D. Tough | ||||
| Chairman of the Board and Chief Executive Officer | ||||
| Dated: May 10, 2011 | By: | /s/ Kevin C. Berryman | ||
| Kevin C. Berryman | ||||
| Executive Vice President and Chief Financial Officer | ||||
28
| Number | Description | |||
| 3.1 |
Bylaws of International Flavors & Fragrances Inc., as amended and
restated March 8, 2011, incorporated by reference to Exhibit 3.1 to
the Companys Report on Form 8-K filed on March 11, 2011.
|
|||
|
|
||||
| 31.1 |
Certification of Douglas D. Tough pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 31.2 |
Certification of Kevin C. Berryman pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|||
|
|
||||
| 32 |
Certification of Douglas D. Tough and Kevin C. Berryman pursuant to
18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act
of 2002.
|
|||
29
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Estée Lauder Companies Inc. | EL |
| L Brands, Inc. | LB |
| Revlon, Inc. | REV |
Suppliers
| Supplier name | Ticker |
|---|---|
| Stepan Company | SCL |
| Sensient Technologies Corporation | SXT |
| Tredegar Corporation | TG |
| Flotek Industries, Inc. | FTK |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|